Sequoia Capital: Investment Portfolio & Startup News
Sequoia Capital
To add a bio or update investment portfolio click update information.
Investment Portfolio


Isomorphic Labs unlocks a £3.8bn Series C round led by Greenoaks and Sequoia Capital to design new medicines with AI
Isomorphic Labs is an AI company focused on designing and developing new medicines. It is building a drug design engine, IsoDDE, made up of foundational simulation AI models that work across multiple therapeutic areas and drug modalities.


Magentic closes £13m Series A led by Felicis to put AI workers inside the procurement teams of global manufacturers
Magentic builds digital workers, called Mages, that work within procurement and supply chain teams at large industrial and manufacturing enterprises. Working through Microsoft Teams, email and a customer's own systems, the agents choose suppliers, negotiate contracts, run orders and clear invoices, while people keep control of key decisions.


Ineffable Intelligence lands over £800m in a seed round led by Sequoia and Lightspeed to develop superintelligence with reinforcement learning
Ineffable Intelligence is an AI research startup developing systems that learn from their own experience to discover new knowledge. It focuses on building a “superlearner” designed to advance reinforcement learning and scientific discovery.


Magentic emerges from stealth with £4m seed led by Sequoia Capital to drive AI savings across global supply chain
Magentic builds AI agents for procurement teams that analyse unstructured supply chain data to identify errors, compliance gaps and cost-saving opportunities across complex manufacturing operations.


Paid lands £8m pre-seed led by EQT Ventures and Sequoia to power monetisation platform for AI agents
Paid provides a monetisation platform for AI agent companies, offering pricing tools and performance dashboards that help businesses manage profitability as software shifts from seats to autonomous agents.
- 3(12 months)
- sequoiacap.com
More venture news
- 17 Nov 2026

Isomorphic LabsIsomorphic Labs unlocks a £3.8bn Series C round led by Greenoaks and Sequoia Capital to design new medicines with AI
Series CLife Sciences - 11 Nov 2026

FractileFractile raises a £540m Series C from investors including Thrive and Founders Fund to build the chips that AI frontiers run on
Series CDeep Tech - 15 Oct 2026

OMass TherapeuticsOMass Therapeutics raises a £230m Series C round from VCs including Bain Capital to develop small molecule therapeutics with drug discovery platform
Series CLife Sciences